Author:
Romaniuk-Drapala Aleksandra,Skupin-Mrugalska Paulina,Garbuzenko Olga,Hatefi Arash,Minko Tamara
Funder
European Union's Horizon 2020 Research and Innovation program, Marie Skłodowska-Curie Action
Ministry of Science and Higher Education of Poland
NIH/NCI
Publisher
Springer Science and Business Media LLC
Reference57 articles.
1. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17–48.
2. Pliarchopoulou K, Pectasides D. Epithelial ovarian cancer: focus on targeted therapy. Crit Rev Oncol Hematol. 2011;79(1):17–23.
3. Reid BM, Permuth JB, Sellers TA. Epidemiology of ovarian cancer: a review. Cancer Biol Med. 2017;14(1):9–32.
4. Kozlowski M, Nowak K, Cymbaluk-Ploska A. Long-term follow-up of a female patient treated with olaparib-hope for a long life without relapse? Int J Environ Res Public Health. 2021;18:7.
5. Zamwar UM, Anjankar AP. Aetiology, epidemiology, histopathology, classification, detailed evaluation, and treatment of ovarian cancer. Cureus. 2022;14(10): e30561.